To sum up, we identified seven genes (GRIA1, GRIA2, GRIK1, GRIK4, GRM3, GLUL, BCAT1) whose mRNA expression may serve as potential molecular biomarker candidates to distinguish glioblastoma and brain metastases tissue derived from surgical resections. The gene discussed is GRIA2; the disease is glioblastoma.